|
1）Kupper N, Willemsen G, Riese H, et al. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension. 2005; 45: 80-5
|
|
|
|
2）Katsuya T, Ishikawa K, Sugimoto K, et al. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003; 26: 521-5
|
|
|
|
|
3）Choi M, Scholl UI, Yue P, et al. K＋ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011; 331: 768-72
|
|
|
|
|
|
4）Boyden LM, Choi M, Choate KA, et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature. 2012; 482: 98-102
|
|
|
|
|
|
5）Louis-Dit-Picard H, Barc J, Trujillano D, et al. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet. 2012; 44: 456-60
|
|
|
|
|
|
6）Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension. 1986; 8: 93-102
|
|
|
|
|
|
7）Wilson FH, Disse-Nicodème S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001; 293: 1107-12
|
|
|
|
|
|
8）Xu B, English JM, Wilsbacher JL, et al. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem. 2000; 275: 16795-801
|
|
|
|
|
|
9）Ohno M, Uchida K, Ohashi T, et al. Immunolocalization of WNK4 in mouse kidney. Histochem Cell Biol. 2011; 136: 25-35
|
|
|
|
|
|
10）Yang SS, Morimoto T, Rai T, et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab. 2007; 5: 331-44
|
|
|
|
|
|
11）Vitari AC, Deak M, Morrice NA, et al. The WNK1 and WNK4 protein kinases that are mutated in Gordonʼs hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J. 2005; 391: 17-24
|
|
|
|
|
|
12）Rafiqi FH, Zuber AM, Glover M, et al. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med. 2010; 2: 63-75
|
|
|
|
|
|
13）Yang SS, Lo YF, Wu CC, et al. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol. 2010; 21: 1868-77
|
|
|
|
|
|
14）Chiga M, Rafiqi FH, Alessi DR, et al. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade. J Cell Sci. 2011; 124: 1391-5
|
|
|
|
|
|
15）Lalioti MD, Zhang J, Volkman HM, et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006; 38: 1124-32
|
|
|
|
|
|
16）Ohta A, Rai T, Yui N, et al. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure. Hum Mol Genet. 2009; 18: 3978-86
|
|
|
|
|
|
17）Castañeda-Bueno M, Cervantes-Pérez LG, Vázquez N, et al. Activation of the renal Na＋: Cl− cotransporter by angiotensin II is a WNK4-dependent process. Proc Natl Acad Sci U S A. 2012; 109: 7929-34
|
|
|
|
|
|
18）Chiga M, Rai T, Yang SS, et al. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int. 2008; 74: 1403-9
|
|
|
|
|
|
19）Talati G, Ohta A, Rai T, et al. Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney. Biochem Biophys Res Commun. 2010; 393: 844-8
|
|
|
|
|
|
20）Mutig K, Saritas T, Uchida S, et al. Short-term stimulation of the thiazide-sensitive Na＋-Cl− cotransporter by vasopressin involves phosphorylation and membrane translocation. Am J Physiol Renal Physiol. 2010; 298: F502-9
|
|
|
|
|
|
21）Vallon V, Schroth J, Lang F, et al. Expression and phosphorylation of the Na＋-Cl− cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am J Physiol Renal Physiol. 2009; 297: F704-12
|
|
|
|
|
|
22）Naito S, Ohta A, Sohara E, et al. Regulation of WNK1 kinase by extracellular potassium. Clin Exp Nephrol. 2011; 15: 195-202
|
|
|
|
|
|
23）Sohara E, Rai T, Yang SS, et al. Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney. PLoS One. 2011; 6: e24277
|
|
|
|
|
|
24）Nishida H, Sohara E, Nomura N, et al. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice. Hypertension. 2012; 60: 981-90
|
|
|
|
|
|
25）Albagli O, Dhordain P, Deweindt C, et al. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ. 1995; 6: 1193-8
|
|
|
|
|
|
26）Adams J, Kelso R, Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol. 2000; 10: 17-24
|
|
|
|
|
|
27）Furukawa M, He YJ, Borchers C, et al. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol. 2003; 5: 1001-7
|
|
|
|
|
|
28）Cirak S, von Deimling F, Sachdev S, et al. Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy. Brain. 2010; 133: 2123-35
|
|
|
|
|
|
29）Dhanoa BS, Cogliati T, Satish AG, et al. Update on the Kelch-like (KLHL) gene family. Hum Genomics. 2013; 7: 13
|
|
|
|
|
|
30）Ohta T, Iijima K, Miyamoto M, et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 2008; 68: 1303-9
|
|
|
|
|
|
31）Wakabayashi M, Mori T, Isobe K, et al. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. Cell Rep. 2013; 3: 858-68
|
|
|
|
|
|
32）Mori Y, Wakabayashi M, Mori T, et al. Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms. Biochem Biophys Res Commun. 2013; 439: 30-4
|
|
|
|
|
|
33）Ohta A, Schumacher FR, Mehellou Y, et al. The CUL3-KLHL3 E3 ligase complex mutated in Gordonʼs hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J. 2013; 451: 111-22
|
|
|
|
|
|
34）Takahashi D, Mori T, Wakabayashi M, et al. KLHL2 interacts with and ubiquitinates WNK kinases. Biochem Biophys Res Commun. 2013; 437: 457-62
|
|
|
|
|